Psychedelic Drugs Market Report – 2025 Outlook, Trends, Share, Size & Forecast
MarkNtel Advisors has unveiled its latest research report on the Psychedelic Drugs Market, providing an in-depth analysis of market dynamics, growth prospects, and competitive landscape. This report serves as a valuable resource for stakeholders aiming to capitalize on emerging opportunities and navigate potential challenges in the Psychedelic Drugs industry.
Psychedelic Drugs Market Size: 2025 Outlook
The Global Psychedelic Drugs Market size was valued at around USD 1.92 billion in 2024 and is projected to reach USD 3.8 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30. Increasing awareness about mental health and government Initiatives raising the demand for psychedelic drugs. As per the WHO (World Health Organization), the Global Mental Health, and World Federation for Mental Health, have increased their attention towards mental health and its awareness among consumers worldwide. For instance, the National Alliance of Mental Illness NAMI in 2022, revealed that every year, about 21% of adults in the U.S. are affected by some or other mental health issue and less than half of this population seek professional guidance. Many of them are not aware of the various treatment options.
U.S. tariffs are changing—are you prepared? Download your free sample PDF of the report for timely data and expert advice – https://www.marknteladvisors.com/query/request-sample/psychedelic-drugs-market.html
📘 Scope of the Report
- Forecasts till 2030 with year-wise market breakdown
- Geographical and segment-level analysis
- Company profiles and strategic insights
- Key market drivers and restraints
- Analysis of market trends and investment opportunities
What’s Driving the Market?
Growing Prevalence of Mental Illness – The prevalence of mental illness varies by age and sex and has increased more rapidly than other serious illnesses. There has been an increase in instances of mental health conditions, including anxiety, sleep-wake disorder, and depressive disorders. For instance, as per a survey by MedlinePlus, it was found that excessive time spent on social media was associated with anxiety, depression, negative body image, and psychological distress. It is estimated that 72% of Americans use social media which affects their mental health.
What’s Holding Back Growth?
High Research and Development Costs – Therapies entail expensive clinical trials that must comply with extremely rigorous regulatory requirements given their history as controlled substances. Such clinical trials are very capital-intensive to be used to ensure safety and efficacy, including strict adherence to the ethical standards set. The novel pharmacological action of psychedelics necessitates specific research that increases the research and development costs.
Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/psychedelic-drugs-market.html
Use your official business email to connect with our team and enjoy full access with priority support.
Psychedelic Drugs Market Segmentation
By Source
- Synthetic -Market Size & Forecast 2020-2030 USD Million
- Natural- Market Size & Forecast 2020-2030, USD Million
By Drugs
- Gamma-Hydroxybutyric Acid-Market Size & Forecast 2020-2030, USD Million
- Ketamine-Market Size & Forecast 2020-2030, USD Million
- Psilocybin-Market Size & Forecast 2020-2030, USD Million
- Lysergic Acid Diethylamide (LSD)-Market Size & Forecast 2020-2030, USD Million
- MethylEnedioxyMethamphetamine-Market Size & Forecast 2020-2030, USD Million
By Application
- Narcolepsy-Market Size & Forecast 2020-2030, USD Million
- Treatment Resistant Depression-Market Size & Forecast 2020-2030, USD Million
- Major Depressive Disorder-Market Size & Forecast 2020-2030, USD Million
- Opiate Addiction-Market Size & Forecast 2020-2030, USD Million
- Post-Traumatic Stress Disorder-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
By Route of Administration
- Oral
- Inhalation-Market Size & Forecast 2020-2030, USD Million
- Injectable-Market Size & Forecast 2020-2030, USD Million
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
🏢 Industry Leaders: Who’s Dominating the Psychedelic Drugs Market?
The market is highly competitive, with players launching innovation-driven products and investing in strategic partnerships. Key participants include:
- Jazz Pharmaceuticals, Inc. (U.S.)
- Janssen Pharmaceuticals, Inc. (U.S.)
- Product Portfolio
- Hikma Pharmaceuticals PLC (U.K.)
- Compass
- Pfizer Inc.
- Avadel
- AbbVie Inc.
- Celon Pharma
- GH Research
- Entheon Biomedical Corp
- PharmaTher Holdings Ltd.
- Usona Institute
- Cybin Corp.
- Hoffmann-La Roche Ltd
- AstraZeneca PLC
- Numinus Wellness Inc.
These companies are focused on health-based R&D, expansion, and functional ingredient diversification.
Looking for Global, Regional or country-specific reports on this market?
Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support - https://www.marknteladvisors.com/query/request-customization/psychedelic-drugs-market.html
🧠 Frequently Asked Questions (FAQs)
- What are the main drivers of the Psychedelic Drugs market?
- Which segment leads the Psychedelic Drugs industry?
- What regulatory challenges impact product development?
- Who are the top players in the Psychedelic Drugs industry?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us:
MarkNtel Advisors LLP
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
For Sales Enquiries: sales@marknteladvisors.com